Per Andersson

764 total citations
18 papers, 644 citations indexed

About

Per Andersson is a scholar working on Physiology, Immunology and Allergy and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Per Andersson has authored 18 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 10 papers in Immunology and Allergy and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Per Andersson's work include Asthma and respiratory diseases (11 papers), Food Allergy and Anaphylaxis Research (7 papers) and Allergic Rhinitis and Sensitization (6 papers). Per Andersson is often cited by papers focused on Asthma and respiratory diseases (11 papers), Food Allergy and Anaphylaxis Research (7 papers) and Allergic Rhinitis and Sensitization (6 papers). Per Andersson collaborates with scholars based in Sweden, Austria and Denmark. Per Andersson's co-authors include Ulf Pipkorn, Morgan Andersson, Håkan Bergstrand, Jan M. Lundberg, Claes‐Roland Martling, Alois Saria, E. Gordon, Christer Lindqvist, A. Rudehill and C. G. A. Persson and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Allergy and Clinical Immunology and British Journal of Pharmacology.

In The Last Decade

Per Andersson

18 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Andersson Sweden 14 403 215 192 104 102 18 644
Jun Hiroi Japan 11 266 0.7× 113 0.5× 113 0.6× 172 1.7× 118 1.2× 23 671
A. Mistretta Italy 19 650 1.6× 484 2.3× 82 0.4× 146 1.4× 168 1.6× 57 949
J.‐P. Rihoux Belgium 19 590 1.5× 134 0.6× 575 3.0× 106 1.0× 20 0.2× 41 995
Francesca Bertolini Italy 13 357 0.9× 210 1.0× 78 0.4× 96 0.9× 114 1.1× 44 688
A.A. Norris United Kingdom 12 162 0.4× 110 0.5× 48 0.3× 95 0.9× 60 0.6× 26 402
Anita Annaházi Hungary 14 113 0.3× 31 0.1× 27 0.1× 177 1.7× 53 0.5× 30 736
Sonja Rittchen Austria 8 127 0.3× 46 0.2× 25 0.1× 181 1.7× 41 0.4× 13 455
Toshinori Kanemura Japan 11 202 0.5× 222 1.0× 11 0.1× 125 1.2× 97 1.0× 37 510
Éva Huszár Hungary 12 254 0.6× 266 1.2× 29 0.2× 75 0.7× 23 0.2× 25 562
Kimio Konno Pakistan 11 158 0.4× 229 1.1× 10 0.1× 169 1.6× 47 0.5× 47 574

Countries citing papers authored by Per Andersson

Since Specialization
Citations

This map shows the geographic impact of Per Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Andersson more than expected).

Fields of papers citing papers by Per Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Andersson. The network helps show where Per Andersson may publish in the future.

Co-authorship network of co-authors of Per Andersson

This figure shows the co-authorship network connecting the top 25 collaborators of Per Andersson. A scholar is included among the top collaborators of Per Andersson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Andersson. Per Andersson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Colombo, Stefano, Jakob Haglöf, Peter Sjövall, et al.. (2015). Matrix effects in nilotinib formulations with pH-responsive polymer produced by carbon dioxide-mediated precipitation. International Journal of Pharmaceutics. 494(1). 205–217. 22 indexed citations
2.
Andersson, Per, Mikael von Euler, & Michael Beckert. (2014). Comparable pharmacokinetics of 85 mg RightSize nilotinib (XS003) and 150 mg Tasigna in healthy volunteers using a hybrid nanoparticle-based formulation platform for protein kinase inhibitors.. Journal of Clinical Oncology. 32(15_suppl). e13551–e13551. 8 indexed citations
3.
Andersson, Per, et al.. (2013). Carbon Dioxide-Mediated Generation of Hybrid Nanoparticles for Improved Bioavailability of Protein Kinase Inhibitors. Pharmaceutical Research. 31(3). 694–705. 37 indexed citations
4.
Rudehill, A., et al.. (1993). Pharmacokinetics and Effects of Mannitol on Hemodynamics, Blood and Cerebrospinal Fluid Electrolytes, and Osmolality During Intracranial Surgery. Journal of Neurosurgical Anesthesiology. 5(1). 4–12. 53 indexed citations
5.
Andersson, Morgan, Per Andersson, & Ulf Pipkorn. (1989). Allergen-induced Specific and Non-specific Nasal ReactionsReciprocal Relationship and Inhibition by Topical Glucocorticosteroids. Acta Oto-Laryngologica. 107(3-4). 270–277. 37 indexed citations
6.
Persson, C. G. A., Per Andersson, & B. Gustafsson. (1989). Budesonide Reduces Sensitivity to Antigen but Does Not Alter Baseline Tone or Responsiveness to Carbachol, Terbutaline, and Enprofylline in IgE-Sensitized Guinea-Pig Tracheae. International Archives of Allergy and Immunology. 88(4). 381–385. 2 indexed citations
7.
Andersson, Per & C. G. A. Persson. (1988). Developments in Anti-Asthma Glucocorticoids. Birkhäuser Basel eBooks. 23. 239–260. 14 indexed citations
8.
Andersson, Per, et al.. (1988). Effect of Glucocorticosteroid Treatment on Ovalbumin-Induced IgE-Mediated Immediate and Late Allergic Response in Guinea Pig. International Archives of Allergy and Immunology. 87(1). 32–39. 18 indexed citations
9.
Andersson, Morgan, Per Andersson, & Ulf Pipkorn. (1988). Topical glucocorticosteroids and allergen-induced increase in nasal reactivity: Relationship between treatment time and inhibitory effect. Journal of Allergy and Clinical Immunology. 82(6). 1019–1026. 47 indexed citations
10.
Martling, Claes‐Roland, Alois Saria, Per Andersson, & Jan M. Lundberg. (1984). Capsaicin pretreatment inhibits vagal cholinergic and non-cholinergic control of pulmonary mechanics in the guinea pig. Naunyn-Schmiedeberg s Archives of Pharmacology. 325(4). 343–348. 64 indexed citations
11.
Andersson, Per & Håkan Bergstrand. (1984). Changes in bronchial anaphylactic reactivity induced in guinea‐pigs by long‐term treatment with histamine H2‐agents. British Journal of Pharmacology. 82(1). 207–216. 5 indexed citations
12.
Andersson, Per. (1982). EFFECTS OF INHIBITORS OF ANAPHYLACTIC MEDIATORS IN TWO MODELS OF BRONCHIAL ANAPHYLAXIS IN ANAESTHETIZED GUINEA‐PIGS. British Journal of Pharmacology. 77(2). 301–307. 42 indexed citations
13.
Pipkorn, Ulf & Per Andersson. (1982). Budesonide and Nasal Mucosal Histamine Content and Anti‐IgE Induced Histamine Release. Allergy. 37(8). 591–595. 16 indexed citations
14.
Andersson, Per. (1981). Antigen-Induced Bronchial Anaphylaxis in Actively Sensitized Guinea Pigs. The Effect of Booster Injection and Cyclophosphamide Treatment. International Archives of Allergy and Immunology. 64(3). 249–258. 33 indexed citations
15.
Andersson, Per & Håkan Bergstrand. (1981). ANTIGEN‐INDUCED BRONCHIAL ANAPHYLAXIS IN ACTIVELY SENSITIZED GUINEA‐PIGS: EFFECT OF LONG‐TERM TREATMENT WITH SODIUM CROMOGLYCATE AND AMINOPHYLLINE. British Journal of Pharmacology. 74(3). 601–609. 49 indexed citations
16.
Andersson, Per. (1980). ANTIGEN‐INDUCED BRONCHIAL ANAPHYLAXIS IN ACTIVELY SENSITIZED GUINEA‐PIGS: ANTI‐ANAPHYLACTIC EFFECTS OF SODIUM CROMOGLYCATE AND AMINOPHYLLINE. British Journal of Pharmacology. 69(3). 467–472. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026